Form 4 for AIP Arteris, Inc.
Accepted 2026-06-04 18:58:53 ET · period of report 2026-06-02 · accession 0001184563-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-04 18:58 | 2026-06-02 | AIP | RAZA SAIYED ATIQ | Dir | A - Grant | $0.00 | +4,703 | 25.5K | +23% | $0 |
| T | 2026-06-04 18:58 | 2026-06-03 | AIP | RAZA SAIYED ATIQ | Dir | G - Gift | $0.00 | -20.8K | 4,703 | -82% | $0 |
| TI | 2026-06-04 18:58 | 2026-06-03 | AIP | RAZA SAIYED ATIQ | Dir | G - Gift | $0.00 | +20.8K | 160.8K | +15% | $0 |
| MTI | 2026-06-04 18:58 | 2026-06-03 | AIP | RAZA SAIYED ATIQ | Dir | S - Sale | $37.39 | -20.8K | 140.0K | -13% | -$779.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | A | A | 4,703 | $0.00 | 25,542 | D | — | — | (F1) Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89. |
| 2 | Common | Common Stock | 2026-06-03 | G | D | 20,839 | $0.00 | 4,703 | D | — | — | (F2) The shares are transferred to Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the reporting person is the trustee. |
| 3 | Common | Common Stock | 2026-06-03 | G | A | 20,839 | $0.00 | 160,839 | I By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | — | — | (F3) The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee. |
| 4 | Common | Common Stock | 2026-06-03 | S | D | 8,332 | $37.65 | 152,507 | I By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | — | — | (F4) Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.32 to $38.27 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2026-06-03 | S | D | 800 | $38.46 | 151,707 | I By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | — | — | (F4) Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. (F6) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.33 to $38.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2026-06-03 | S | D | 11,707 | $37.13 | 140,000 | I By Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | — | — | (F4) Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. (F7) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.32 to $37.31 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |